Expression of Concern: Tumor Suppressor MicroRNA-27a in Colorectal Carcinogenesis and Progression by Targeting SGPP1 and Smad2 (PLoS ONE (2014) 9: 8 (e105991) DOI: 10.1371/journal.pone.0105991);Tumor suppressor MicroRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Bao, Yonghua ^a   Chen, Zhiguo ^a   Guo, Yongchen ^a   Feng, Yansheng ^a   Li, Zexin ^a   Han, Wenliang ^a   Wang, Jianguo ^a   Zhao, Weixing ^a   Jiao, Yunjuan ^a   Li, Kai ^a   Wang, Qian ^a   Wang, Jiaqi ^a   Zhang, Huijuan ^a   Wang, Liang ^a,b   Yang, Wancai ^a,c  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MICRORNA; MICRORNA 27A; SMAD2 PROTEIN; SPHINGOSINE 1 PHOSPHATE PHOSPHATASE 1; STAT3 PROTEIN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; MIRN27 MICRORNA, HUMAN; PHOSPHATASE; SGPP1 PROTEIN, HUMAN; SMAD2 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; COLON MUCOSA; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOGENESIS; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PREDICTION; PROTEIN CLEAVAGE; SGPP1 GENE; SMAD2 GENE; TUMOR GENE; UPREGULATION; ANIMAL; BIOLOGY; C57BL MOUSE; CACO 2 CELL LINE; CANCER TRANSPLANTATION; COLORECTAL TUMOR; GENETICS; HCT116 CELL LINE; METABOLISM; METASTASIS; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

ANIMALS; CACO-2 CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; HCT116 CELLS; HUMANS; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHOSPHORIC MONOESTER HYDROLASES; SMAD2 PROTEIN;

EID: 84928961742     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0280980     Document Type: Erratum

References (45)

1. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
2. Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. The Journal of pathology 223: 102-115.
3. Di Leva G, Garofalo M, Croce CM (2014) MicroRNAs in Cancer. Annual review of pathology 9: 287-314.
4. Garofalo M, Leva GD, Croce CM (2014) MicroRNAs as Anti-Cancer Therapy. Current pharmaceutical design Jan 28. [Epub ahead of print].
5. White NM, Fatoohi E, Metias M, Jung K, Stephan C, et al. (2011) Metastamirs: a stepping stone towards improved cancer management. Nature reviews 8: 75-84.
6. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America 103: 2257-2261. (Pubitemid 43271657)
7. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Lages E, Ipas H, Guttin A, Nesr H, Berger F, et al. (2012) MicroRNAs: molecular features and role in cancer. Frontiers in bioscience (Landmark edition) 17: 2508-2540.
9. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, et al. (2002) Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295: 1726-1729. (Pubitemid 34202910)
10. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer research 67: 11001-11011. (Pubitemid 350145930)
11. Tang W, Yu F, Yao H, Cui X, Jiao Y, et al. (2013) miR-27a regulates endothelial differentiation of breast cancer stem like cells. Oncogene Jun 10. doi:10.1038/onc.2013.214. [Epub ahead of print].
12. Tang W, Zhu J, Su S, Wu W, Liu Q, et al. (2012) MiR-27 as a prognostic marker for breast cancer progression and patient survival. PloS one 7: e51702.
13. Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, et al. (2012) 3′-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. Cancer research 72: 1467-1477.
14. Chintharlapalli S, Papineni S, Abdelrahim M, Abudayyeh A, Jutooru I, et al. (2009) Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. International journal of cancer 125: 1965-1974.
15. Pathi SS, Jutooru I, Chadalapaka G, Sreevalsan S, Anand S, et al. (2011) GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. Mol Cancer Res 9: 195-202.
16. Huang S, He X, Ding J, Liang L, Zhao Y, et al. (2008) Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. International journal of cancer 123: 972-978. (Pubitemid 352032429)
17. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC (2006) Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer research 66: 1277-1281. (Pubitemid 43259904)
18. Zhu L, Wang Z, Fan Q, Wang R, Sun Y (2014) microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS. Oncology reports 31: 280-286.
19. Venkatesh T, Nagashri MN, Swamy SS, Mohiyuddin SM, Gopinath KS, et al. (2013) Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma. PloS one 8: e54643.
20. Scheibner KA, Teaboldt B, Hauer MC, Chen X, Cherukuri S, et al. (2012) MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3theta. PloS one 7: e50895.
21. Acunzo M, Romano G, Palmieri D, Lagana A, Garofalo M, et al. (2013) Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2. Proceedings of the National Academy of Sciences of the United States of America 110: 8573-8578.
22. Yang K, Popova NV, Yang WC, Lozonschi I, Tadesse S, et al. (2008) Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer research 68: 7313-7322.
23. Bao Y, Guo Y, Li Z, Fang W, Yang Y, et al. (2014) MicroRNA profiling in Muc2 knockout mice of colitis-associated cancer model reveals epigenetic alterations during chronic colitis malignant transformation. PloS One 9(6): e99132.
24. Tong C, Yin Z, Song Z, Dockendorff A, Huang C, et al. (2007) c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. Am J Pathol 171: 297-303. (Pubitemid 47339246)
25. Bi X, Tong C, Dockendorff A, Bancroft L, Gallagher L et al. (2008) Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis 29: 1435-1440.
26. Bi X, Pohl NM, Qian Z, Yang GR, Gou Y, et al. (2012) Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 33: 326-330.
27. Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318-1321. (Pubitemid 16002234)
28. Yang W, Velcich A, Lozonschi I, Liang J, Nicholas C, et al. (2005) Inactivation of p21WAF1/cip1 Enhances Intestinal Tumor Formation in Muc2-/- Mice. Am J Pathol 166: 1239-1246. (Pubitemid 40524446)
29. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, et al. (2006) Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131: 117-129. (Pubitemid 44015753)
30. Johnson KR, Johnson KY, Becker KP, Bielawski J, Mao C, et al. (2003) Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. The Journal of biological chemistry 278: 34541-34547. (Pubitemid 37553303)
31. Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, et al. (2013) Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer cell 23: 107-120.
32. Yang J, Wahdan-Alaswad R, Danielpour D (2009) Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells. Cancer research 69: 2185-2190.
33. Brown KA, Pietenpol JA, Moses HL (2007) A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. Journal of cellular biochemistry 101: 9-33. (Pubitemid 46652569)
34. Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, et al. (2013) Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget 4: 1388-1398.
35. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr., et al. (2013) Cancer genome landscapes. Science 339: 1546-1558.
36. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
37. Antonioli L, Blandizzi C, Pacher P, Hasko G (2013) Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer 13: 842-857.
38. Petersson J, Schreiber O, Hansson GC, Gendler SJ, Velcich A, et al. (2011) Importance and regulation of the colonic mucus barrier in a mouse model of colitis. American journal of physiology 300: G327-333.
39. Danese S, Mantovani A (2010) Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene 29: 3313-3323.
40. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer cell 15: 103-113.
41. Bromberg J, Wang TC (2009) Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer cell 15: 79-80.
42. Nguyen AV, Wu YY, Liu Q, Wang D, Nguyen S, et al. (2013) STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon. Neoplasia (New York, NY 15: 998-1008.
43. Fleming NI, Jorissen RN, Mouradov D, Christie M, Sakthianandeswaren A, et al. (2013) SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer research 73: 725-735.
44. Horiguchi K, Shirakihara T, Nakano A, Imamura T, Miyazono K, et al. (2009) Role of Ras signaling in the induction of snail by transforming growth factor-beta. The Journal of biological chemistry 284: 245-253.
45. Zhao BM, Hoffmann FM (2006) Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA. Molecular biology of the cell 17: 3819-3831. (Pubitemid 44330868)